As described above, PI3K/Akt/mTOR signaling pathway serve as the main mechanism related to the resistance to EGFR-TKIs induced by ARID1A alterations and expression loss in NSCLC patients. This evidence concerns the gene MTOR and non-small cell lung carcinoma.